Characteristic

Data for patients who received

Vancomycin

FDC

Evaluable patients

59

54

Sex ratio―male:female [n (%)]

37:22 (62.71%:37.29%)

32:22 (59.25%:40.75%)

Age, mean year SD

58.47 ± 14.67

59.85 ± 13.99

APACHE II score

<15

44 (74.57%)

41 (75.92%)

≥15

15 (25.43%)

13 (24.08%)

Co-morbidities

Diabetes mellitus

18 (30.50%)

19 (35.18%)

Cardiac

27 (45.76%)

23 (42.59%)

Kidney

7 (11.86%)

4 (7.40%)

Chronic obstructive pulmonary disease (COPD)

33 (55.93%)

35 (64.81%)

Neurological disease

9 (15.25%)

10 (18.51%)

Pneumonia types

Community associated

8 (13.55%)

7 (12.96%)

Health care-associated

26 (44.06%)

28 (51.85%)

Hospital associated

22 (37.28%)

15 (27.77%)

Ventilator associated

31 (52.54%)

28 (51.85%)